Clinical Trial Update: An Efficacy and Safety Study of Low-dose Transdermal Therapeutic System (TTS)-Fentanyl D-Trans in Taiwan Participants With Cancer Pain [Phase 4]

View source ↗

Summary

Phase 4 trial update reporting efficacy and safety of a low-dose fentanyl transdermal system in Taiwan patients with cancer-related pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Fentanyl transdermal system (low-dose TTS-D-Trans) (fentanyl)

Snippet

Sponsor: Janssen-Cilag Ltd. | Conditions: Cancer, Pain | Phase 4 | Status: COMPLETED